Small interfering RNA targeting survivin sensitizes lung cancer cell with mutant p53 to adriamycin

作者: Kimio Yonesaka , Kenji Tamura , Takayasu Kurata , Taroh Satoh , Masato Ikeda

DOI: 10.1002/IJC.21350

关键词:

摘要: Survivin is a member of the inhibitor apoptosis protein (IAP) family that specifically overexpressed in cancer tissues. p53 one tumor suppressor genes; its induction response to DNA damage causes and correlates with drug sensitivity. To investigate possible regulation survivin by p53, we examined level expression lung cell lines adriamycin. Levels mRNA wild-type decreased dramatically after induction, but no such reduction was observed mutated or null p53. Inhibition A549 cells small interfering (si) RNA significantly upregulated survivin. inhibition siRNA PC9 depressed proliferation. sensitivity adriamycin survivin, using siRNA, then added at an IC50 dose. After further 48 hr incubation adriamycin, proliferation treated targeting comparison scramble. Furthermore, both TUNEL pro-caspase3 assay showed significant increase combined treatment Our results demonstrate downregulated increases promotes apoptosis. could be potentially useful for increasing anticancer drugs, especially drug-resistant ' 2005 Wiley-Liss, Inc.

参考文章(36)
Rui Hua Xiang, Susan L. Naylor, Alan Y. Sakaguchi, Charles H. Hensel, Use of the single strand conformation polymorphism technique and PCR to detect p53 gene mutations in small cell lung cancer. Oncogene. ,vol. 6, pp. 1067- 1071 ,(1991)
Hua Meng, Expression level of wild-type survivin in gastric cancer is an independent predictor of survival World Journal of Gastroenterology. ,vol. 10, pp. 3245- 3250 ,(2004) , 10.3748/WJG.V10.I22.3245
T Mitsudomi, Seth M Steinberg, Marion M Nau, David Carbone, Domenico D'Amico, Sara Bodner, Herbert K Oie, R Ilona Linnoila, James L Mulshine, John D Minna, None, p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene. ,vol. 7, pp. 171- 180 ,(1992)
Dario C. Altieri, Toshiyuki Tenjo, Cai-De Lu, Nobuhiko Tanigawa, Masao Toyoda, Hiroshi Kawasaki, Inhibition of Apoptosis by Survivin Predicts Shorter Survival Rates in Colorectal Cancer Cancer Research. ,vol. 58, pp. 5071- 5074 ,(1998)
Yves Pommier, Dario C. Altieri, Janet Plescia, Daniel S. O'Connor, Nathan R. Wall, Suppression of survivin phosphorylation on Thr34 by flavopiridol enhances tumor cell apoptosis. Cancer Research. ,vol. 63, pp. 230- 235 ,(2003)
Sayda M. Elbashir, Jens Harborth, Winfried Lendeckel, Abdullah Yalcin, Klaus Weber, Thomas Tuschl, Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells Nature. ,vol. 411, pp. 494- 498 ,(2001) , 10.1038/35078107
Fengzhi Li, Grazia Ambrosini, Emily Y. Chu, Janet Plescia, Simona Tognin, Pier Carlo Marchisio, Dario C. Altieri, Control of apoptosis and mitotic spindle checkpoint by survivin. Nature. ,vol. 396, pp. 580- 584 ,(1998) , 10.1038/25141
Mariano Monzó, Rafael Rosell, Enriqueta Felip, Julio Astudillo, José Javier Sánchez, José Maestre, Cristina Martín, Albert Font, Agustí Barnadas, Albert Abad, A Novel Anti-Apoptosis Gene: Re-expression of Survivin Messenger RNA as a Prognosis Marker in Non–Small-Cell Lung Cancers Journal of Clinical Oncology. ,vol. 17, pp. 2100- 2100 ,(1999) , 10.1200/JCO.1999.17.7.2100
C.G. Ferreira, C. Tolis, G. Giaccone, p53 and chemosensitivity Annals of Oncology. ,vol. 10, pp. 1011- 1021 ,(1999) , 10.1023/A:1008361818480
Dominic A. Scudiero, Nicole Vigna, Ed Sausville, John C. Reed, Ingo Tamm, Tilman Oltersdorf, Yan Wang, IAP-Family Protein Survivin Inhibits Caspase Activity and Apoptosis Induced by Fas (CD95), Bax, Caspases, and Anticancer Drugs Cancer Research. ,vol. 58, pp. 5315- 5320 ,(1998)